These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1258 related items for PubMed ID: 17229635

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
    Nanni C, Zamagni E, Farsad M, Castellucci P, Tosi P, Cangini D, Salizzoni E, Canini R, Cavo M, Fanti S.
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):525-31. PubMed ID: 16453155
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma.
    Mesguich C, Hulin C, Latrabe V, Lascaux A, Bordenave L, Hindié E, Marit G.
    Ann Hematol; 2020 Dec; 99(12):2869-2880. PubMed ID: 32951093
    [Abstract] [Full Text] [Related]

  • 5. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS.
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [Abstract] [Full Text] [Related]

  • 6. Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial.
    Mesguich C, Hulin C, Latrabe V, Asselineau J, Bordenave L, Perez P, Hindie E, Marit G.
    JMIR Res Protoc; 2020 Sep 10; 9(9):e17850. PubMed ID: 32909953
    [Abstract] [Full Text] [Related]

  • 7. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
    Fonti R, Pace L, Cerchione C, Catalano L, Salvatore B, De Luca S, Pane F, Salvatore M, Del Vecchio S.
    Clin Nucl Med; 2015 Apr 10; 40(4):303-8. PubMed ID: 25608167
    [Abstract] [Full Text] [Related]

  • 8. A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET/CT, 18F-NaF-PET/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients.
    Dyrberg E, Hendel HW, Al-Farra G, Balding L, Løgager VB, Madsen C, Thomsen HS.
    Acta Radiol Open; 2017 Oct 10; 6(10):2058460117738809. PubMed ID: 29123920
    [Abstract] [Full Text] [Related]

  • 9. DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approach.
    Jamet B, Necib H, Carlier T, Frampas E, Bazin J, Desfontis PH, Monnet A, Bodet-Milin C, Moreau P, Touzeau C, Kraeber-Bodere F.
    Cancer Imaging; 2024 Jul 11; 24(1):93. PubMed ID: 38992707
    [Abstract] [Full Text] [Related]

  • 10. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
    Albano D, Patti C, Lagalla R, Midiri M, Galia M.
    J Magn Reson Imaging; 2017 Apr 11; 45(4):1082-1089. PubMed ID: 27603267
    [Abstract] [Full Text] [Related]

  • 11. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A.
    J Nucl Med; 2015 Dec 11; 56(12):1862-8. PubMed ID: 26405167
    [Abstract] [Full Text] [Related]

  • 12. ¹⁸F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review.
    van Lammeren-Venema D, Regelink JC, Riphagen II, Zweegman S, Hoekstra OS, Zijlstra JM.
    Cancer; 2012 Apr 15; 118(8):1971-81. PubMed ID: 21887677
    [Abstract] [Full Text] [Related]

  • 13. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
    Nanni C, Rubello D, Zamagni E, Castellucci P, Ambrosini V, Montini G, Cavo M, Lodi F, Pettinato C, Grassetto G, Franchi R, Gross MD, Fanti S.
    In Vivo; 2008 Apr 15; 22(4):513-7. PubMed ID: 18712181
    [Abstract] [Full Text] [Related]

  • 14. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y, Kawai H, Iwano S, Ito S, Ogawa H, Naganawa S.
    J Med Imaging Radiat Oncol; 2013 Jun 15; 57(3):297-305. PubMed ID: 23721138
    [Abstract] [Full Text] [Related]

  • 15. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ.
    J Nucl Med; 2014 Feb 15; 55(2):191-7. PubMed ID: 24309383
    [Abstract] [Full Text] [Related]

  • 16. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
    Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V.
    Clin Exp Med; 2015 Feb 15; 15(1):1-18. PubMed ID: 25218739
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic performance of 18F-FDG PET/CT and whole-body MRI before and early after treatment of multiple myeloma: a prospective comparative study.
    Basha MAA, Hamed MAG, Refaat R, AlAzzazy MZ, Bessar MA, Mohamed EM, Ahmed AF, Tantawy HF, Altaher KM, Obaya AA, Afifi AHM.
    Jpn J Radiol; 2018 Jun 15; 36(6):382-393. PubMed ID: 29671193
    [Abstract] [Full Text] [Related]

  • 18. Hybrid simultaneous whole-body 2-[18F]FDG-PET/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value results.
    Jamet B, Carlier T, Bailly C, Bodet-Milin C, Monnet A, Frampas E, Touzeau C, Moreau P, Kraeber-Bodere F.
    Eur Radiol; 2023 Sep 15; 33(9):6438-6447. PubMed ID: 37022439
    [Abstract] [Full Text] [Related]

  • 19. State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settings.
    Mesguich C, Fardanesh R, Tanenbaum L, Chari A, Jagannath S, Kostakoglu L.
    Eur J Radiol; 2014 Dec 15; 83(12):2203-2223. PubMed ID: 25308249
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic Significance of 18F-FDG PET/CT Imaging Coupled with Magnetic Resonance Imaging of the Entire Body for Bone Metastases.
    Guo H, Zhang Z, Wang L, Yao S, Xu S, Ma S, Liu S.
    Contrast Media Mol Imaging; 2022 Dec 15; 2022():7717398. PubMed ID: 36247843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.